Back to search

Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus

Data up to Jan 2025

Published1994
Citations64
References49

Total Citations Per Year

Abstract

References (49)

Pathogenesis of Foreign Body Infection: Description and Characteristics of an Animal Model

1982 • 610 citations

Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis

1991 • 587 citations

Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response

1990 • 405 citations

Correlation between In Vivo and In Vitro Efficacy of Antimicrobial Agents against Foreign Body Infections

1990 • 314 citations

Clinical Pharmacokinetics of Teicoplanin

1990 • 253 citations

Resistance to vancomycin and teicoplanin: an emerging clinical problem

1990 • 235 citations

Antibiotic Tolerance Among Clinical Isolates of Bacteria

1985 • 208 citations

Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis

1990 • 170 citations

Staphylococcus aureus Endocarditis

1978 • 159 citations

Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations

1991 • 142 citations

Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus

1990 • 138 citations

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

1992 • 134 citations

Early Termination of a Prospective, Randomized Trial Comparing Teicoplanin and Flucloxacillin for Treating Severe Staphylococcal Infections

1987 • 132 citations

Resistance of Staphylococcus aureus Recovered from Infected Foreign Body In Vivo to Killing by Antimicrobials

1991 • 119 citations

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

1991 • 112 citations

Treatment of Experimental Chronic Osteomyelitis Due to Staphylococcus aureus with Vancomycin and Rifampin

1983 • 111 citations

Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo Correlations

1985 • 102 citations

Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents

1985 • 101 citations

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis

1990 • 98 citations

Microbiological properties of teicoplanin

1988 • 95 citations

Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin

1991 • 90 citations

Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin

1990 • 87 citations

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

1986 • 86 citations

Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters

1989 • 81 citations

A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria

1988 • 79 citations

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

1989 • 79 citations

Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics

1993 • 76 citations

A review of the safety profile of teicoplanin

1991 • 74 citations

Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections

1983 • 69 citations

Teicoplanin

1984 • 66 citations

Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients

1987 • 65 citations

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

1991 • 63 citations

Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis

1990 • 63 citations

Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection

1990 • 60 citations

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections

1987 • 60 citations

Dosage recommendations for teicoplanin

1993 • 57 citations

Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus

1984 • 54 citations

Teicoplanin in the treatment of gram-positive-bacterial endocarditis

1989 • 51 citations

Clinical efficacy and safety of teicoplanin

1988 • 44 citations

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results

1988 • 43 citations

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus

1984 • 36 citations

Teicoplanin Compared with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis

1986 • 28 citations

Teicoplanin monotherapy of serious infections caused by Gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial

1991 • 28 citations

Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus

1994 • 25 citations

Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin

1990 • 23 citations

Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with teicoplanin

1986 • 21 citations

Clinical efficacy of teicoplanin

1990 • 18 citations

Activity of teicoplanin in localized experimental infections in rats

1986 • 12 citations

Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus

1987 • 11 citations

Cited By (0)

Loading...
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and… (1994) – Antimicrobial Agents and Chemotherapy | Metascience Observatory Explorer